31 December 2022

Biosimilar medicines monitored by the NIHR Innovation Observatory

This dashboard provides an overview of biosimilar medicines that have been monitored by the NIHR Innovation Observatory on our internal database, MInD, since April 2017. It provides the user with the details of the biosimilar products including the therapeutic condition, development status, trial details and EU and UK approval information.